Žádné výsledky... Zkuste upravit dotaz a/nebo upravit či vypnout filtry
Nejvíce citovaný článek - PubMed ID 37865771
Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study
Orphanet journal of rare diseases.
2023 Oct 21 ;
18 (1) :
332.
[epub] 20231021